| Recruitment status | Completed |
| Unique ID issued by UMIN | UMIN000045109 |
| Receipt No. | R000051496 |
| Scientific Title | A cross-sectional study for the search of blood parameters associated with risk markers of lifestyle-related disease |
| Date of disclosure of the study information | 2021/08/12 |
| Last modified on | 2022/08/16 (Ver. 6) |
| Basic information | ||
| Public title | A cross-sectional study for the search of blood parameters associated with risk markers of lifestyle-related disease | |
| Acronym | A cross-sectional study for the search of blood parameters associated with risk markers of lifestyle-related disease | |
| Scientific Title | A cross-sectional study for the search of blood parameters associated with risk markers of lifestyle-related disease | |
| Scientific Title:Acronym | A cross-sectional study for the search of blood parameters associated with risk markers of lifestyle-related disease | |
| Region |
|
|
| Condition | ||
| Condition | N/A | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | This study examine the association between risk markers of lifestyle-related diseases and blood parameters |
| Basic objectives2 | Others |
| Basic objectives -Others | N/A |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | The association between risk markers of lifestyle-related disease and blood parameters |
| Key secondary outcomes | |
| Base | |
| Study type | Observational |
| Study design | |
| Basic design | |
| Randomization | |
| Randomization unit | |
| Blinding | |
| Control | |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | |
| No. of arms | |
| Purpose of intervention | |
| Type of intervention | |
| Interventions/Control_1 | |
| Interventions/Control_2 | |
| Interventions/Control_3 | |
| Interventions/Control_4 | |
| Interventions/Control_5 | |
| Interventions/Control_6 | |
| Interventions/Control_7 | |
| Interventions/Control_8 | |
| Interventions/Control_9 | |
| Interventions/Control_10 | |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | (1) Healthy male and female subjects (>=40 to >70 years of age)
(2) Subjects whose BMI values are between normal-high and obesity class 1 (>=23 to <30 kg/m2) (3) Subjects whose fasting blood glucose levels are <126 mg/dL and 2-hour blood glucose levels are <200 mg/dL during oral glucose tolerance test (4) Subjects who participate in this study with a written informed consent |
|||
| Key exclusion criteria | (1) Subjects who have dietary carbohydrate restriction and try to lose weight or who plan to have dietary carbohydrate restriction and lose weight during the scheduled study period
(2) Subjects who consecutively intake pharmaceutical and healthcare foods (which is possible to influence the results of this study) at 3 or more times per week (3) Subjects who plan to change their daily habit (diet, exercise) and living environment (changing residence, employee relocation, et al.) during the scheduled study period (4) Subjects with extremely irregular dietary habits (5) Subjects with excessive alcohol intake (6) Subjects with excessive smoking (7) Subjects who are positive for hepatitis C virus antibody or hepatitis B surface antigen (8) Subjects who allergies to medication or foods (especially soybean and gelatin) (9) Subjects who are participating in another trial, have participated in the past 4 weeks, or plan to participate in another trial during the scheduled study period (10) Females who have pregnancy, lactation, plan to have pregnancy (11) Subjects who receive medical treatment or have a history of severe disease (12) Subjects who have made a platelet donation or a blood donation of 200 mL within one month prior to this study (13) Males who have made a blood donation of 400 mL within three months (14) Females who have made a blood donation of 400 mL within four months (15) Males who have made a blood donation over an amount (1200 mL minus the estimated volume of blood collected during to this study) within one year prior to this study (16) Females who have made a blood donation over an amount (800 mL minus the estimated volume of blood collected during to this study) within one year prior to this study (17) Subjects judged to be unsuitable for the study for other reasons by the investigators |
|||
| Target sample size | 440 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | House Wellness Foods Corporation | ||||||
| Division name | Research & Development Institute | ||||||
| Zip code | 664-0011 | ||||||
| Address | Imoji 3-20, Itami, Hyogo, Japan | ||||||
| TEL | 072-778-1127 | ||||||
| Yamamoto_Yoshihiro@house-wf.co.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | House Wellness Foods Corporation | ||||||
| Division name | Research & Development Institute | ||||||
| Zip code | 664-0011 | ||||||
| Address | Imoji 3-20, Itami, Hyogo, Japan | ||||||
| TEL | 072-778-1127 | ||||||
| Homepage URL | |||||||
| Uchio_Ryusei@house-wf.co.jp | |||||||
| Sponsor | |
| Institute | Research & Development Institute, House Wellness Foods Corporation |
| Institute | |
| Department | |
| Funding Source | |
| Organization | House Wellness Foods Corporation |
| Organization | |
| Division | |
| Category of Funding Organization | Profit organization |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | Institutional Review Board of Chiyoda Paramedical Care Clinic |
| Address | 2F Sanwa-Uchi-Kanda Building, 3-3-5 Uchi-Kanda, Chiyoda-ku, Tokyo 101-0047, Japan |
| Tel | 03-5297-5548 |
| IRB@cpcc.co.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | 431 |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Completed | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | None |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000051496 |